Literature DB >> 25469208

[The interest in the assay of serum calcium before a maxillary tumor: discovery of primary hyperparathyroidism].

Hicham Esselmani1, Mounya Bouabdellah2, Laila Benchekroun2, Sanae Elalami1, Najat Handor1, Layachi Chabraoui2.   

Abstract

Entities:  

Keywords:  brown maxillary tumor; hypercalcemia; primary hyperparathyroidism

Mesh：

Substances：

Year:  2014        PMID： 25469208      PMCID： PMC4247893          DOI： 10.11604/pamj.2014.18.315.4967

Source DB:  PubMed          Journal:  Pan Afr Med J


× No keyword cloud information.
  14 in total

Review 1.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.

Authors:  John P Bilezikian; John T Potts; Ghada El-Hajj Fuleihan; Michael Kleerekoper; Robert Neer; Munro Peacock; Jonas Rastad; Shonni J Silverberg; Robert Udelsman; Samuel A Wells
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

2.  Brown tumor of the mandible as first manifestation of atypical parathyroid adenoma.

Authors:  Maria Mercedes Suarez-Cunqueiro; Ralf Schoen; Astrid Kersten; Joachim Klisch; Rainer Schmelzeisen
Journal:  J Oral Maxillofac Surg       Date:  2004-08       Impact factor: 1.895

3.  [Tumor of the maxilla presenting as primary hyperparathyroidism].

Authors:  B El-Abdi; I Berrkia; A Mohssine; My R El-Hassani; A El-Quessar; N Chakir; N Boukhrissi; M Jiddane
Journal:  J Radiol       Date:  2006-11

Review 4.  Evaluation and management of primary hyperparathyroidism.

Authors:  S J Silverberg; J P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  1996-06       Impact factor: 5.958

Review 5.  The epidemiology of primary hyperparathyroidism in North America.

Authors:  L Joseph Melton
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

Review 6.  Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features.

Authors:  J P Bilezikian; M L Brandi; M Rubin; S J Silverberg
Journal:  J Intern Med       Date:  2005-01       Impact factor: 8.989

7.  Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism.

Authors:  Karin Frank-Raue; Gudrun Leidig-Bruckner; Christine Haag; Egbert Schulze; Angela Lorenz; Hubertus Schmitz-Winnenthal; Friedhelm Raue
Journal:  Clin Endocrinol (Oxf)       Date:  2011-07       Impact factor: 3.478

8.  Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism.

Authors:  Shonni J Silverberg; Ping Gao; Ijeoma Brown; Paul LoGerfo; Tom L Cantor; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

Review 9.  [Primary hyperparathyroidism].

Authors:  J-L Wémeau
Journal:  J Radiol       Date:  2009-03

10.  Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.

Authors:  H Lowe; D J McMahon; M R Rubin; J P Bilezikian; S J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2007-05-29       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.